EurekAlert! - National Institutes of Health

Showing releases 26-50 out of 117 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 ]

Public Release: 28-Oct-2009
NIEHS awards Recovery Act funds to address bisphenol A research gaps
Researchers studying the health effects of the chemical bisphenol A (BPA) gathered in North Carolina to launch an integrated research initiative to produce data that will allow for a comprehensive assessment of its possible human health effects.

NIH/National Institute of Environmental Health Sciences

Public Release: 28-Oct-2009
Recovery Act funds expand studies of stem cell biology
NIH's National Institute of General Medical Sciences is using $5.4 million of Recovery Act funds to accelerate basic studies of induced pluripotent stem cells. These cells are reprogrammed from skin or other easily obtained adult cells and appear to be similar to stem cells derived from embryos.

NIH/National Institute of General Medical Sciences

Public Release: 28-Oct-2009

Lancet
A decade later, lifestyle changes or metformin still lower type 2 diabetes risk
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent compared with placebo in people at high risk for the disease, researchers conclude based on 10 years of data.

Public Release: 28-Oct-2009

Nature
NIH-funded researchers transform embryonic stem cells into human germ cells
Researchers funded in part by the National Institutes of Health have discovered how to transform human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs. The advance will allow researchers to observe human germ cells -- previously inaccessible -- in laboratory dishes.

National Institutes of Health

Public Release: 21-Oct-2009

New England Journal of Medicine
Study conclusively ties rare disease gene to Parkinson's
An international team led by a National Institutes of Health researcher has found that carriers of a rare, genetic condition called Gaucher disease face a risk of developing Parkinson's disease more than five times greater than the general public. The findings were published today in the New England Journal of Medicine.

National Institutes of Health

Public Release: 16-Oct-2009
NIH launches second phase of patient reported outcomes initiative
The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System. Managed by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, PROMIS aims to revolutionize the way patient reported outcome tools are selected and employed in clinical research and practice.

National Institutes of Health

Public Release: 15-Oct-2009

Science
Scientists discover protein receptor for carbonation taste
Scientists report they have discovered the protein receptor for carbonatoin in mice, whose sense of taste closely resembles that of humans.

NIH/National Institute of Dental and Craniofacial Research, Howard Hughes Medical Institute

Public Release: 12-Oct-2009

Archives of Neurology
Investment in Parkinson's disease data bank yields potential therapy
Individuals with Parkinson's disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health. A clinical trial is under way to examine the safety and potential benefits of supplemental urate elevation for recently diagnosed Parkinson's patients who have low urate levels.

National Institutes of Health, Michael J. Fox Foundation

Public Release: 9-Oct-2009
NIH prepares to launch 2009 H1N1 influenza vaccine trial in people with asthma
The National Institutes of Health is preparing to launch the first government-sponsored clinical trial to determine what dose of the 2009 H1N1 influenza vaccine is needed to induce a protective immune response in people with asthma, especially those with severe disease. The study is cosponsored by the National Institute of Allergy and Infectious Diseases and the National Heart, Lung and Blood Institute, both part of NIH.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 9-Oct-2009
NIH launches 2009 H1N1 influenza vaccine trials in HIV-infected pregnant women
The first clinical trials to test whether the 2009 H1N1 influenza vaccine can safely elicit a protective immune response in pregnant women launched yesterday, and a trial to conduct the same test in HIV-infected children and youth will begin next week. The International Maternal Pediatric Adolescent AIDS Clinical Trials Group is conducting the studies, which are sponsored and funded by the National Institute of Allergy and Infectious Diseases and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 8-Oct-2009

Symposium on Cardiovascular Regenerative Medicine
NHLBI to convene symposium on cardiovascular regenerative medicine
With advancements in the field of stem cell research accelerating, the National Heart, Lung and Blood Institute of the National Institutes of Health will hold its third Symposium on Cardiovascular Regenerative Medicine to review the latest findings in the field and examine future directions. The symposium will include a discussion on ways to move promising findings in the laboratory into clinical trials, in hopes of speeding stem cell-related treatments to patients.

Public Release: 8-Oct-2009
NIAID announces vaccine adjuvant discovery contracts
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded six new research contracts to discover and characterize novel adjuvants, substances that can be added to vaccines to enhance the protective immune response they induce.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 6-Oct-2009
NIDCR launches the FaceBase Consortium
Although about half of all birth defects involve the face and skull, scientists remain unclear about why most occur. The NIH's National Institute of Dental and Craniofacial Research announced it has issued the first 11 research and technology grants of its new FaceBase Consortium. The five-year initiative will systematically compile the biological instructions to construct the middle region of the human face and precisely define the genetics underlying its common developmental disorders, such as cleft lip and palate.

NIH/National Institute of Dental and Craniofacial Research

Public Release: 5-Oct-2009
NIH announces expansion of Rare Diseases Clinical Research Network
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network including funds for 19 research consortia. The Rare Diseases Clinical Research Consortia and a Data Management Coordinating Center will be awarded a total of just over $117 million over the next five years. The research conducted with the new funding will explore the natural history, epidemiology, diagnosis, and treatment of more than 95 rare diseases.

National Institutes of Health

Public Release: 2-Oct-2009
NIDDK announces availability of more current kidney disease data
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the US Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients.

Public Release: 1-Oct-2009
NIH grants $152 million in Institutional Development Awards
The National Center for Research Resources, part of the National Institutes of Health, announced today it will provide up to an estimated $152 million over the next five years to fund Institutional Development Award Networks of Biomedical Research Excellence in nine IDeA-eligible states.

NIH/National Center for Research Resources

Public Release: 1-Oct-2009

Journal of Virology
Frozen assets: NIAID researchers turn to unique resource for clues to norovirus evolution
A search through decades-old frozen infant stool samples has yielded rich dividends for NIAID scientists. The team customized a laboratory technique to screen thousands of samples for norovirus, a major cause of acute gastroenteritis outbreaks in people of all ages. What they discovered about the rate of evolution of a specific group of noroviruses could help researchers develop specific antiviral drugs and, potentially, a vaccine against a disease that is very unpleasant and sometimes deadly.

NIH/National Insitute of Allergy and Infection Diseases

Public Release: 30-Sep-2009

New England Journal of Medicine
Treating even mild gestational diabetes reduces birth complications
A National Institutes of Health network study provided the first conclusive evidence that treating pregnant women who have even the mildest form of gestational diabetes can reduce the risk of common birth complications among infants, as well as blood pressure disorders among mothers.

National Institutes of Health

Public Release: 27-Sep-2009
NIH funds 4 Centers of Excellence in genomic science
The National Human Genome Research Institute (NHGRI) and National Institute of Mental Health (NIMH), both part of the National Institutes of Health, today announced grants expected to total approximately $45 million to establish new Centers of Excellence in Genomic Science in Wisconsin and North Carolina, as well as to continue support of existing centers in Maryland and California.

NIH/National Human Genome Research Institute, NIH/National Institute of Mental Health

Public Release: 24-Sep-2009
Research needed to learn which DCIS patients may be candidates for less invasive therapy
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance. An independent panel convened by the NIH urged researchers to identify appropriate biomarkers and other prognostic factors to better predict the risk of developing breast cancer.

Public Release: 24-Sep-2009
NIH announces 115 awards to encourage high-risk research and innovation
The National Institutes of Health announced today that it is awarding $348 million to encourage investigators to explore bold ideas that have the potential to catapult fields forward and speed the translation of research into improved health.

National Institutes of Health

Public Release: 24-Sep-2009

Emerging Infectious Diseases
Study finds nontuberculous mycobacteria lung disease on the rise in the United States
Nontuberculous mycobacteria (NTM) are environmental organisms found in both water and soil that can cause severe pulmonary (lung) disease in humans. Pulmonary NTM is on the rise in the United States, according to a large study of people hospitalized with the condition.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 24-Sep-2009
HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 24-Sep-2009

New England Journal of Medicine
Scientists identify genetic cause of previously undefined primary immune deficiency disease
Researchers at the National Institutes of Health have identified a genetic mutation that accounts for a perplexing condition found in people with an inherited immunodeficiency. The disorder, called combined immunodeficiency, is characterized by a constellation of severe health problems, including persistent bacterial and viral skin infections, severe eczema, acute allergies and asthma and cancer.

NIH/National Institute of Allergy and Infectious Diseases

Public Release: 21-Sep-2009
Early results: In children, 2009 H1N1 influenza vaccine works like seasonal flu vaccine
Early results from a trial testing a 2009 H1N1 influenza vaccine in children look promising. Preliminary analysis of blood samples from a small group of trial participants shows that a single 15-microgram dose of a nonadjuvanted 2009 H1N1 influenza vaccine -- the same dose that is in the seasonal flu vaccine � generates an immune response that is expected to be protective against 2009 H1N1 influenza virus in the majority of 10- to 17-year-olds eight to 10 days following vaccination.

NIH/National Institute of Allergy and Infectious Diseases

Showing releases 26-50 out of 117 releases.
Click to go to page: [ 1 | 2 | 3 | 4 | 5 ]